Edition:
India

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

157.12USD
1:30am IST
Change (% chg)

$0.22 (+0.14%)
Prev Close
$156.90
Open
$156.81
Day's High
$157.20
Day's Low
$154.90
Volume
443,375
Avg. Vol
765,012
52-wk High
$256.78
52-wk Low
$142.83

Select another date:

Fri, Apr 20 2018

BRIEF-Allergan confirms does not intend to make Shire

* ALLERGAN NOW CONFIRMS THAT IT DOES NOT INTEND TO MAKE AN OFFER FOR SHIRE Source text for Eikon: Further company coverage: (Reporting by Maiya Keidan)

Shire rejects $63 billion Takeda bid as Allergan drops pursuit

NEW YORK/LONDON Rare disease drug maker Shire Plc said on Thursday it had rejected a $63 billion cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd , while Allergan Plc reversed course on pursuing a rival bid.

Shire rejects $63 billion Takeda bid as Allergan drops pursuit

NEW YORK/LONDON Rare disease drug maker Shire Plc said on Thursday it had rejected a $63 billion cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd , while Allergan Plc reversed course on pursuing a rival bid.

UPDATE 5-Shire rejects $63 bln Takeda bid as Allergan drops pursuit

* Shire takeover fights follows surge in drug sector M&A (Adds new Allergan statement)

BRIEF-Allergan Does Not Intend To Make An Offer For Shire; Strategic Review Continues

* ALLERGAN DOES NOT INTEND TO MAKE AN OFFER FOR SHIRE PLC; STRATEGIC REVIEW CONTINUES

BRIEF-Allergan Confirms It Is In Early Stages Of Considering Possible Offer For Shire

* ALLERGAN ISSUES STATEMENT REGARDING PRESS SPECULATION ON ITS STRATEGIC REVIEW

Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources

Botox maker Allergan Plc is in talks to acquire Shire Plc, competing against Japan's Takeda Pharmaceutical Co Ltd for the London-listed drugmaker, two sources familiar with the matter said on Thursday.

Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources

Botox maker Allergan Plc is in talks to acquire Shire Plc, competing against Japan's Takeda Pharmaceutical Co Ltd for the London-listed drugmaker, two sources familiar with the matter said on Thursday.

BRIEF-Allergan Announced Official Launch Of TrueTear

* ANNOUNCED OFFICIAL LAUNCH OF TRUETEAR Source text for Eikon: Further company coverage:

BRIEF-Myokardia Announces Appointment Of Taylor C. Harris As Chief Financial Officer

* MYOKARDIA ANNOUNCES APPOINTMENT OF TAYLOR C. HARRIS AS CHIEF FINANCIAL OFFICER

Select another date: